Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
Recruiting · NCT04337580 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Cancer, Castration-Resistant, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, refractory malignant neoplasm | Recruiting | Phase 2 | 2026-04-13 | NCT04337580 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Wake Forest University Health Sciences | 284 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| W.G. Bill Hefner VA Medical Center | Salisbury | United States | 1 |
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | United States | 26 |